Headquartered in Leamington, Canada, Tilray Brands, Inc. (TLRY) is a global leader in medical cannabis research and development, cultivation, production, marketing, and distribution, with operations in four segments: Cannabis Business; Distribution Business; Beverage Alcohol Business; and Wellness Business.
In a recent move to bolster its cannabis portfolio, TLRY's medical cannabis division, Tilray Medical, and its Italian subsidiary, FL Group, received authorization from Italy’s Ministry of Health to distribute three new medical cannabis compounds.
